Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 600 of 3284 entries
View as:

A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole

Phase: N/A Priority: Normal
NCT ID: NCT04564040 Org: User:
Start: 10/12/20 End: 12/11/20 Due: 12/11/21

Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension

Phase: N/A Priority: Normal
NCT ID: NCT02305680 Org: User:
Start: 12/17/14 End: 04/05/17 Due: 04/05/18

Study in Healthy Subjects to Measure the Effects of Food on the Pharmacokinetics of TC-5214

Phase: N/A Priority: Normal
NCT ID: NCT01458899 Org: User:
Start: 11/30/11 End: 01/31/12 Due: 01/31/13

Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00079833 Org: User:
Start: 11/30/03 End: 07/31/05 Due: 07/31/06

Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00706914 Org: User:
Start: 06/30/08 End: 11/11/08 Due: 11/11/09

A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)

Phase: N/A Priority: Normal
NCT ID: NCT03521154 Org: User:
Start: 07/19/18 End: 06/29/26 Due: 06/29/27

Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04592913 Org: User:
Start: 11/17/20 End: 09/27/27 Due: 09/27/28

Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan

Phase: N/A Priority: Normal
NCT ID: NCT03063710 Org: User:
Start: - End: - Due: -

Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt

Phase: N/A Priority: Normal
NCT ID: NCT01635959 Org: User:
Start: 07/31/12 End: 07/31/14 Due: 07/31/15

Analysis of Antihypertensive Treatment Efficacy

Phase: N/A Priority: Normal
NCT ID: NCT00767247 Org: User:
Start: 05/31/08 End: 02/28/09 Due: 02/28/10

Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD

Phase: N/A Priority: Normal
NCT ID: NCT00489853 Org: User:
Start: 07/31/07 End: 08/31/08 Due: 08/31/09

Observational Usage Study of Statins in Primary Care in France

Phase: N/A Priority: Normal
NCT ID: NCT00680082 Org: User:
Start: 02/29/08 End: 07/31/09 Due: 07/31/10

An Epidemiological Study of Acute Coronary Syndromes in The Greek Population. The TARGET Study

Phase: N/A Priority: Normal
NCT ID: NCT01061086 Org: User:
Start: 01/31/10 End: 02/28/11 Due: 02/28/12

Predictive Questionnaires for Risk of Acute COPD (Chronic Obstructive Pulmonary Disease) Exacerbations

Phase: N/A Priority: Normal
NCT ID: NCT01248507 Org: User:
Start: 01/31/11 End: 04/30/13 Due: 04/30/14

A Study to Assess the Drug Absorption Into the Blood After Administration of 3 Doses of AZD5718

Phase: N/A Priority: Normal
NCT ID: NCT04087187 Org: User:
Start: 09/20/19 End: 10/31/19 Due: 10/31/20

To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656

Phase: N/A Priority: Normal
NCT ID: NCT01083212 Org: User:
Start: 03/31/10 End: 06/30/10 Due: 06/30/11

Asthma Control and Clinical Practice in Hungary 2009

Phase: N/A Priority: Normal
NCT ID: NCT00900861 Org: User:
Start: 04/30/09 End: 11/30/09 Due: 11/30/10

To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02476968 Org: User:
Start: 09/28/15 End: 12/17/21 Due: 12/17/22

To Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of Olaparib, and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation to Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT01900028 Org: User:
Start: 10/31/13 End: 09/30/16 Due: 09/30/17

Adherence Study in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02864342 Org: User:
Start: 08/12/16 End: 10/31/17 Due: 10/31/18

Randomised Double-Blind, Placebo-Controlled, Parallel Group Study in Patients With Active Rheumatoid Arthritis:Magnetic Resonance Imaging Sub-Study

Phase: N/A Priority: Normal
NCT ID: NCT02092961 Org: User:
Start: 02/28/11 End: 07/31/13 Due: 07/31/14

A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04556773 Org: User:
Start: 12/17/20 End: 12/04/25 Due: 12/04/26

Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01473758 Org: User:
Start: 02/29/12 End: 03/31/14 Due: 03/31/15

PROPE Severe Asthma Study in Egypt

Phase: N/A Priority: Normal
NCT ID: NCT06283290 Org: User:
Start: 03/12/24 End: 11/28/24 Due: 11/28/25

Impact of GERD on Daily Life (NIS)

Phase: N/A Priority: Normal
NCT ID: NCT00545883 Org: User:
Start: 06/30/06 End: 03/31/08 Due: 03/31/09